| Interventions for acne scars RA Hay, K Shalaby, H Zaher, V Hafez, CC Chi, S Dimitri, AF Nabhan, ... Cochrane Database of Systematic Reviews, 2016 | 114 | 2016 |
| Lactate dehydrogenase a depletion alters MyC-CaP tumor metabolism, microenvironment, and CAR T cell therapy MM Mane, IJ Cohen, E Ackerstaff, K Shalaby, JN Ijoma, M Ko, M Maeda, ... Molecular Therapy-Oncolytics 18, 382-395, 2020 | 21 | 2020 |
| Outcomes of acute pulmonary embolism in hospitalized patients with cancer K Shalaby, A Kahn, ES Silver, MJ Kim, K Balakumaran, AS Kim BMC Pulmonary Medicine 22, 1-7, 2022 | 20 | 2022 |
| Mediastinal irradiation and valvular heart disease S Patil, SR Pingle, K Shalaby, AS Kim Cardio-Oncology 8 (1), 7, 2022 | 16 | 2022 |
| Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858R MJ Hadfield, A Turshudzhyan, K Shalaby, A Reddy Journal of Oncology Pharmacy Practice 28 (3), 717-721, 2022 | 3 | 2022 |
| Phase 2 study of abatacept, ixazomib, and dexamethasone in patients with relapsed/refractory multiple myeloma. K Shalaby, L Carlson, K Celotto, C Chavel, I Lund, K McCaffrey, ... Journal of Clinical Oncology 41 (16_suppl), 8030-8030, 2023 | 1 | 2023 |
| Subdural Hemorrhage Due to Acquired Von Willebrand Syndrome in a Patient With Polycythemia Vera K Shalaby, JC Lima, R Szulawski Cureus 13 (7), 2021 | | 2021 |
| AMAN ASSOCIATED WITH GROUP A STREPTOCOCCUS BACTEREMIA V Kesarwani, K Shalaby JOURNAL OF GENERAL INTERNAL MEDICINE 36 (SUPPL 1), S196-S197, 2021 | | 2021 |
| 654 Real world incidence of grade III and higher adverse effects, emergency room utilization and hospital admissions during treatment with commonly used PD-1/PDL-1 targeting … NL Lia, SI Jafri, K Shalaby, D Drekolias, J Vredenburgh Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Lymphoma-Associated Pulmonary Embolism Burden in Hospital Admissions in the United States K Shalaby, A Kahn, E Silver, K Balakumaran, AS Kim Blood 134, 3400, 2019 | | 2019 |
| The effect of lactate dehydrogenase-A (LDH-A) knockdown and human prostate-specific membrane antigen (hPSMA) directed CAR T-cell treatment on hPSMA (+) Myc-CaP tumors MM Mane, K Shalaby, I Cohen, A Albeg, J Ijoma, M Ko, M Maeda, ... CANCER IMMUNOLOGY RESEARCH 7 (2), 2019 | | 2019 |
| Abstract A089: The effect of lactate dehydrogenase-A (LDH-A) knockdown and human prostate-specific membrane antigen (hPSMA) directed CAR T-cell treatment on hPSMA (+) Myc-CaP … MM Mane, K Shalaby, I Cohen, A Albeg, J Ijoma, M Ko, M Maeda, ... Cancer Immunology Research 7 (2_Supplement), A089-A089, 2019 | | 2019 |
